CRISPRMED25 - Interview: Avencia Sánchez-Mejías (Integra Therapeutics)

CRISPRMED25 is an event not to be missed, but don't take it from us! Hear what some of CRISPRMED24 attendees have to say about the conference in this new video series by WeDoCRISPR!

By: WeDoCRISPR - Feb. 3, 2025

How can attending CRISPRMED help your start-up company?

In our latest CRISPRMED testimonial, Avencia Sánchez-Mejías, CEO of Integra Therapeutics, reflects on the challenges that biotech startups face and how attending CRISPRMED helped her company connect with other CRISPR experts from both academia and the industry.

See you at CRISPRMED25?

CRISPRMED25 is the second edition of the biggest European CRISPR Medicine Conference, organised by CRISPR Medicine News. Listen to worldwide experts, participate in illustrating workshops and network with other CRISPR scientists from industry and academia, all dedicated to bringing CRISPR to the clinic.

Did Avencia's testimony convince you to register to CRISPRMED25? Register here before April 4th.
Get more information about CRISPRMED25 here.